Document:

TIDS
NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES
SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THERULESANDREGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT")

 

us
$85,000.00

 

REGEN
BIOPHARMA, INC.

8%
CONVERTIBLE REDEEMABLE NOTE

DUE
AUGUST 23, 2018

BACK
END 

 

 

FOR
VALUE RECEIVED, Regen Biopharma, Inc. (the "Company") promises to pay to the order of GS CAPITAL PARTNERS, LLC and its
authorized successors and permitted as signs ("Holder"), the aggregate principal face amount of Eighty Five Thousand
Dollars exactly (U.S. $85,000.00) on August 23, 2018 ("Maturity Date") and to pay interest on the principal amount
outstanding hereunder at the rate of 8% per annum commencing on August 23, 2017. The interest will be paid to the Holder in whose
name this Note is registered on the records of the Company regarding registration and transfers of this Note. The principal of,
and interest on, this Note are payable at 110 Wall Street, Suite 5-070 New York, NY 10005, initially, and if
changed, last appearing on the records of the Company as designated in writing by the Holder hereof from time to time.
The Company will pay each interest payment and the outstanding principal due upon this Note before or the Maturity Date, less
any amounts required by law to be deducted or withheld, to the Holder of this Note by check or wire transfer addressed to such
Holder at the last address appearing on the records of the Company. The forwarding of such check or wire transfer shall constitute
a payment of outstanding principal hereunder and shall satisfy and discharge the liability for principal on this Note to the extent
of the sum represented by such check or wire transfer. Interest shall be payable in Common Stock (as defined below) pursuant to
paragraph 4(b) herein.

 

This
Note is subject to the following additional provisions:

 

1.
This Note is exchangeable for an equal aggregate principal amount of different authorized denominations, as requested by the
Holder surrendering the same.

.

    	 	1	 

     

    

 

No
service charge will be made for such registration or transfer or exchange, except that Holder shall pay any tax or other
governmental charges payable in connection therewith.

 

2.
The Company shall be entitled to withhold from all payments any amounts required to be withheld under applicable
laws.

 

3.
This Note may be transferred or exchanged only in compliance with the Securities Act of 1933, as amended ("Act") and
applicable state securities laws. Any attempted transfer to a non-qualifying party shall be treated by the Company as void.
Prior to due present ment for transfer of this Note, the Company and any agent of the Company may treat the person in
whose name this Note is duly registered on the Company's records as the owner hereof for all other purposes, whether or not
this Note be overdue, and neither the Company nor any such agent shall be affected or bound by notice to the contrary. Any
Holder of this Note electing to exercise the right of conversion set forth in Section 4(a) hereof, in addition to the
requirements set forth in Section 4(a), and any prospective transferee of this Note, also is required to give the Company
written confirmation that this Note is being converted ("Notice of Conversion") in the form annexed hereto
as Exhibit A. The date of receipt (including receipt by telecopy) of such Notice of Conversion shall be the Conversion
Date.

 

4.
(a) The Holder of this Note is entitled, at its option, at any time after the 6 month anniversary of this Note, to convert
all or any amount of the principal face amount of this Note then outstanding into shares of the Company's common stock (the "Common
Stock") at a price ("Conversion Price") for each share of Common Stock equal to 65% of the lowest
VWAP of the Common Stock as reported on the National Quotations Bureau OTC Markets ex change which the
Company's shares are traded or any exchange upon which the Common Stock may be traded in the future ("Exchange"),
for the fourteen prior trading days including the day upon which a
Notice of Conversion is received by the Company or its transfer agent (provided such Notice of Conversion is delivered by fax
or other electronic method of communication to the Company or its transfer agent after 4 P.M. Eastern
Standard or Daylight Savings Time if the Holder wishes to include the same day closing price). If the shares have not been
delivered with in 3 business days, the Notice of Conversion may be rescinded. Such conversion shall be effectuated by the
Company delivering the shares of Common Stock to the Holder within 3 business days of receipt by the Company of the Notice of
Conversion. Accrued but unpaid interest shall be subject to conversion. No fractional shares or scrip representing fractions
of shares will be is sued on conversion, but the number of shares issuable shall be rounded to the nearest whole share. To
the extent the Conversion Price of the Company's Common Stock closes below the par value per share, the Company will take
all steps necessary to solicit the consent of the stockholders to reduce the par value to the lowest value possible under
law. The Company agrees to honor all conversions submitted pending this increase. In the event the Company experiences a
DTC "Chill" on its shares, the conversion price shall be decreased to 55% instead of 65% while that
"Chill" is in effect. In no event shall the Holder be allowed to effect a conversion if such conversion, along
with all other shares of Company Common Stock beneficially owned by the Holder and its affiliates would exceed 9.9% of
the outstanding shares of the Common Stock of the Company. The conversion discount and look back period will be adjusted on a
ratchet basis if the Company offers a more favorable conversion discount (whether through a straight discount or in
combination with an original issue discount) or look back period to another party while this note is in effect.

 

    	 	2	 

     

    

 

(b)
Interest on any unpaid principal balance of this Note shall be paid at the rate of 8% per annum. Interest shall be paid
by the Company in Common Stock ("Interest Shares"). Holder may, at any time, send in a Notice of Conversion to the
Company for Interest Shares based on the formula provided in Section 4(a) above. The dollar amount converted into Interest
Shares shall be all or a portion of the accrued interest calculated on the unpaid principal balance of this Note to the date
of such notice.

 

(b)
This Note may not be prepaid, except that if the $85,000 Rule 144 convertible redeemable note issued by the Company of even date
herewith is redeemed by the Company within 6 months of the issuance
date of such Note, all obligations of the Company under this Note and all obligations of the Holder under the Holder issued Back
End Note will be automatically be deemed satisfied and this Note and the Holder issued Back End Note will be automatically be
deemed cancelled and of no further force or effect.

 

(d)
Upon (i) a transfer of all or substantially all of the assets of the Company to any person in a single transaction or series
of related transactions, (ii) a reclassification, capital reorganization or other change or exchange of outstanding shares of
the Common Stock, other than a forward or reverse stock split or stock dividend, or (iii) any consolidation or merger of the
Company with or into another person or entity in which the Company is not the surviving entity (other than a merger which is
effected solely to change the jurisdiction of incorporation of the Company and results in a reclassification, conversion or
exchange of outstanding shares of Common Stock solely into shares of Common Stock) (each of items (i), (ii) and (iii) being
referred to as a "Sale Event"), then, in each case, the Company shall, upon request of the Holder, redeem this
Note in cash for 150% of the principal amount, plus accrued but unpaid interest through the date of redemption, or at the
election of the Holder, such Holder may convert the unpaid principal amount of this Note (together with the amount of
accrued but unpaid interest) into shares of Common Stock immediately prior to such Sale Event at the Conversion
Price.

 

(e)
In case of any Sale Event (not to include a sale of all or substantially all of the Company's assets) in connection with
which this Note is not redeemed or converted, the Company shall cause effective provision to be made so that the Holder of
this Note shall have the right thereafter, by converting this Note, to purchase or convert this Note into the kind and number
of shares of stock or other securities or property (including cash) receivable upon such reclassification, capital
reorganization or other change, consolidation or merger by a holder of the number of shares of Common Stock that could have
been purchased upon exercise of the Note and at the same Conversion Price, as defined in this
Note, immediately prior to such Sale Event. The foregoing provisions shall similarly apply to successive Sale Events. If the
consideration received by the holders of Common Stock is other than cash, the value shall be as deter mined by the
Board of Directors of the Company or successor person or entity acting in good faith.

 

    	 	3	 

     

    

 

5. No provision of this Note shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the
principal of, and interest on, this Note at the time, place, and rate, and in the form, herein prescribed.

 

6. The Company hereby expressly waives demand and presentment for payment, notice of non-payment, protest, notice of protest, notice
of dishonor, notice of acceleration or intent to accelerate, and diligence in taking any action to collect amounts called for
hereunder and shall be directly and primarily liable for the payment of all sums owing and to be owing hereto.

 

7. The Company agrees to pay all costs and expenses, including reasonable attorneys' fees and expenses, which may be incurred by
the Holder in collecting any amount due under this Note.

 

 8. If one or more of the following described "Events of Default" shall occur:

 

(a) The
Company shall default in the payment of principal or interest on this Note or any other note issued to the Holder by the Company;
or

 

(b) Any of the representations or warranties made
by the Company herein or in any certificate or financial or other written statements heretofore or hereafter furnished by or on
behalf of the Company in connection with the execution and delivery of this Note, or the Securities Purchase Agreement under
which this note was issued shall be false or misleading in any respect; or

 

(c) The
Company shall fail to perform or observe, in any respect, any covenant, term, provision,
condition, agreement or obligation of the Company under this Note or any other note issued to the Holder; or

 

(d) The
Company shall (1) become insolvent; (2) admit in writing its inability to pay its debts generally as they mature; (3) make an
assignment for the benefit of creditors or commence proceedings for its dissolution; (4) apply for or consent to the appointment
of a trustee, liquidator or receiver for its or for a substantial part of its property or business; (5) file a petition for
bankruptcy relief, consent to the filing of such petition or have filed against it an involuntary petition for bankruptcy relief,
all under federal or state laws as applicable; or

 

(e) A
trustee, liquidator or receiver shall be appointed for the Company or for a substantial part of its property or business without
its consent and shall not be discharged with in sixty (60) days after such appointment; or

 

(f)
Any governmental agency or any court of competent jurisdiction at the in- stance of any governmental agency shall assume
custody or control of the whole or any substantial portion of the properties or assets of the Company; or

 

    	 	4	 

     

    

 

(g)
One or more money judgments, writs or warrants of attachment, or similar process, in excess of fifty thousand dollars
($50,000) in the aggregate, shall be entered or filed against the Company or any of its properties or other assets and shall
remain unpaid, unvacated, unbonded or unstayed for a period of fifteen (15) days or in any event later than five (5) days
prior to the date of any proposed sale thereunder; or

 

(h) The
Company shall have defaulted on or breached any term of any other note of similar debt instrument into which the Company has entered
and failed to cure such de fault within the appropriate grace period; or

 

(i) The
Company shall have its Common Stock delisted from an exchange (including the OTC Market Exchange) or, if the Common Stock trades
on an exchange, then trading in the Common Stock shall be suspended for more than 10 consecutive days or ceases to file its 1934
act reports with the SEC;

 

(j) If a majority of the members of the Board of
Directors of the Company on the date hereof are no longer serving as members of the Board;

 

(k) The Company shall not deliver to the Holder the
Common Stock pursuant to paragraph 4 herein without restrictive legend within 3 business days of its receipt of a Notice of Conversion;
or

 

(l)
The Company shall not replenish the reserve set forth in Section 12, with- in 3 business days of the request of the Holder.

 

(m)
The Company's Common Stock has a closing bid price of less than $0.01 per share for at least 5 consecutive trading days; or

 

(n)
The aggregate dollar trading volume of the Company's Common Stock is less than twenty thousand
dollars ($20,000.00) in any 5 consecutive trading days; or

 

(o) The
Company shall not be "current" in its filings with the Securities and Exchange Commission;

 

(p) The
Company shall lose the "bid" price for its stock in a market (including the OTC marketplace or other exchange); or

 

Then,
or at any time thereafter, unless cured (except for 8(m) and 8(n) which are incurable de faults, the sole remedy of which
is to allow the Holder to cancel both this Note and the Holder Issued Note, and in each and every such case, unless such Event
of Default shall have been waived in writing by the Holder (which waiver shall not be deemed to be a waiver of any subsequent
default) at the option of the Holder and in the Holder's sole discretion, the Holder may consider this Note immediately due and
payable, without presentment, demand, protest or (further) notice of any kind (other than notice of acceleration), all of which
are hereby expressly waived, anything herein or in any note or other instruments contained to the contrary notwith standing, and
the Holder may immediately, and without expiration of any period of grace, en force any and all of the Holder's rights and remedies
provided herein or any other rights or remedies afforded by law. Upon an Event of Default, interest shall accrue at a default
interest rate of 24% per annum or, if such rate is usurious or not permitted by current law, then at the highest rate of interest
permitted by law. In the event of a breach of Section 8(k) the penalty shall be $250 per
day the shares are not issued beginning on the 4th day after the conversion notice was delivered to the Company. This
penalty shall increase to $500 per day beginning on the 10th day. The penalty for a breach of Section 8(p) shall be
an increase of the outstanding principal amounts by 20%. In case of a breach of Section
8(i), the outstanding principal due under this Note shall increase by 50%. Further, if a breach of Section 8(o) occurs or is continuing
after the 6 month anniversary of the Note, then the Holder shall be entitled to use the lowest closing bid price dur ing the delinquency
period as a base price for the conversion. For example, if the lowest closing bid price during the delinquency period is $0.01
per share and the conversion discount is 50% the Holder may elect to convert future conversions at $0.005 per share. If this Note
is not paid at maturity, the outstanding principal due under this Note shall increase by 10%.

 

    	 	5	 

     

    

 

If
the Holder shall commence an action or proceeding to enforce any provisions of this Note, including, without limitation, engaging
an attorney, then if the Holder prevails in such action, the Holder shall be reimbursed by the Company for its attorneys' fees
and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding.

 

Make-Whole
for Failure to Deliver Loss. At the Holder's election, if the Company fails for any reason to deliver to the Holder the conversion
shares by the by the 3rd business day following the delivery of a Notice of Conversion to the Company and if the Holder incurs
a Failure to Deliver Loss, then at any time the Holder may provide the Company written notice indicating the amounts payable to
the Holder in respect of the Failure to Deliver Loss and the Company must make the Holder whole as follows:

 

Failure
to Deliver Loss = [(Highest VWAP for the 30 trading days on or after the day of exercise) x (Number of conversion shares)]

 

The
Company must pay the Failure to Deliver Loss by cash payment, and any such cash payment must be made by the third business day
from the time of the Holder's written notice to the Company.

 

9. In case any provision of this Note is held by a court of competent jurisdiction to be excessive in scope or otherwise invalid
or unenforceable, such provision shall be adjusted rather than voided, if possible, so that it is enforceable to the maximum
extent possible, and the validity and enforceability of the remaining provisions of this Note will not in
any way be affected or impaired thereby.

 

10.
Neither this Note nor any term hereof may be amended, waived, discharged or terminated other than by a written instrument
signed by the Company and the Holder.

 

11.
The Company represents that it is not a "shell" issuer and has never been a "shell" issuer or that if it
previously has been a "shell" issuer that at least 12 months have passed since the Company has reported form 10
type information indicating it is no longer a "shell issuer. Further. The Company will instruct its counsel to either
(i) write a 144 opinion to allow for salability of the conversion shares or (ii) accept such opinion from Holder's
counsel.

 

12.
The Company shall issue irrevocable transfer agent instructions reserving 17,435,000 shares of its Common Stock for
conversions under this Note (the "Share Reserve"). Upon full conversion of this Note, any shares remaining in the
Share Reserve shall be cancelled. The Company shall pay all transfer agent costs associated with issuing and delivering the
share certificates to Holder. If such amounts are to be paid by the Holder, it may deduct such amounts from the Conversion
Price. The company should at all times reserve a minimum of four times the amount of shares required if the note would be
fully converted. The Holder may reasonably re quest increases from time to time to reserve such amounts. The Company will
instruct its transfer agent to provide the outstanding share information to the Holder in connection with its conversions.

 

    	 	6	 

     

    

 

13.
The Company will give the Holder direct notice of any corporate actions, including but not limited to name changes, stock
splits, recapitalizations etc. This notice shall be given to the Holder as soon as possible under law.

 

14. If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury,
the applicable provision shall automatically be revised to equal the maximum rate of interest or other amount deemed interest
permitted under applicable law. The Company covenants (to the extent that it may lawfully do so) that it will not seek to claim
or take advantage of any law that would prohibit or forgive the Company from paying all or a portion of the principal or interest
on this Note.

 

15. This Note shall be governed by and construed in accordance with the laws of New York applicable to contracts made and wholly to
be performed within the State of New York and shall be binding upon the successors and assigns of each party hereto. The Holder
and the Company hereby mutually waive trial by jury and consent to exclusive jurisdiction and venue in the courts of the State
of New York or in the Federal courts sitting in the county or city of New York. This Agreement may be executed in counterparts,
and the facsimile transmission of an executed counterpart to this Agreement shall be effective as an original.

 

    	 	7	 

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Note to be duly executed by an officer thereunto duly authorized.

 

	Dated: August 24, 2017	 	REGEN BIOPHARMA, INC.
	 	 	 
	 	 	/s/ David
    R. Koos
	 	Title:	David R. Koos
	 	 	Chairman & CEO

 

 

    	 	8	 

     

    

 

EXHIBIT
A

 

 

NOTICE
OF CONVERSION

 

(To
be Executed by the Registered Holder in order to Convert the Note)

 

The
undersigned hereby irrevocably elects to convert $ ___________ of
the above Note into __________ Shares of Common Stock of Regen Biopharma, Inc. ("Shares") according to the
conditions set forth in such Note, as of the date written below.

 

If
Shares are to be issued in the name of a person other than the undersigned, the undersigned will pay all transfer and other truces
and charges payable with respect thereto.

 

 

	Date of Conversion:	 
	Applicable Conversion Price:	 
	 	 	 
	Signature:	 
	[Print Name of Holder and Title of Singer]
	 	 	 
	Address:	 
	 	 
	 	 	 
	SSN or EIN:	 	 
	Shares to be registered in the following name:	 
	 	 	 
	Name	 
	Address:	 
	Tel:	 	 
	FAX:	 	 
	SSN or EIN	 	 
		 	 
	Shares are to be sent or delivered to the following account:
	 	 	 
	Account Name:	 
	Address:	 

 

    	 	9This Business Advisory Board Services Agreement (the "Agreement"), dated October 16, 20I 7,
is entered into between Regen BioPharma, Inc., a Nevada corporation  ("the Company"), and JP Millon 
an individual with a principal place of residence (“'Candidate").

WHEREAS,
the Company desires to retain the services of Candidate for the benefit of the Company and its stockholders; and

WHEREAS,
Candidate desires to serve as Chairman of the Company's Business Advisory Board for the period of time and subject to the
terms and conditions set forth herein;

NOW,
THEREFORE, for consideration and as set forth herein, the parties hereto agree as follows:

 

 

		1.	Board
                                         Duties. Candidate agrees to provide services to the Company as the Chairman of the
                                         Company's Business Advisory Board. Candidate shall, for so long as he remains a member
                                         of the Business Advisory Board, meet with the Company upon written request, at dates
                                         and times mutually agreeable to Candidate and the Company, to discuss any matter involving
                                         the Company or its Subsidiaries

		2.	Other
                                         Duties. Candidate will utilize his best efforts to:

		(a)	Identify
                                         and introduce to the Company persons not previously known to the Company to serve as
                                         members of the Company's Business Advisory Board ("Advisory Candidates").

		(b)	Identify
                                         and introduce to the Company potential purchasers of the Company's securities such purchasers
                                         not previously known to the Company ("Buyers"). Candidate shall solely identify
                                         and introduce Buyers to the Company and shall not, among other things, participate in
                                         any negotiations between a Buyer and the Company, assist in the structure of any offer
                                         or sale of the Company's securities ("Transaction"), provide assistance to
                                         any party in completing a purchase agreement, subscription agreement or other documentation
                                         related to a Transaction or handle the funds or securities involved in any Transaction.

		3.	Term.
                                         The Term of this Agreement shall commence on October 9, 2017 and shall expire on
                                         October 9, 2020. The term of this Agreement may be extended by mutual agreement.

		4.	Independent
                                         Contractor. The Parties are independent contractors. Nothing in this Agreement shall
                                         be deemed to constitute a partnership or joint venture between the Parties or constitute
                                         any Party to be the agent of the other Party for any purpose. The Candidate's relationship
                                         with and role and responsibilities to the Company are purely contractual in nature and
                                         Candidate does not have any fiduciary or other duty to the Company by virtue thereof.

		5.	No
                                         obligation: This Agreement does not constitute an obligation on the part of the Company
                                         to:

		(a)	Enter
                                         into any Transaction with any Buyer

		(b)	Accept
                                         as a member of the Business Advisory Board any Advisory Candidate

 

    	 	1	 

     

    

 

		6.	Mutual
                                         Non-Disparagement. During the term of this Agreement and for a period of twelve months
                                         thereafter, Candidate and the Company mutually agree to forbear from making, causing
                                         to be made, publishing, ratifying or endorsing any and all disparaging remarks, derogatory
                                         statements or comments made to any party with respect to either of them or their respective
                                         officers, directors, and employees. The parties agree and acknowledge that this Section
                                         6 is a material term of this Agreement.

 

		7.	Non-Disclosure.

 

		(a)	All
                                         information, whether in oral, written, graphic, electronic or other form, disclosed by
                                         the Company to the Candidate shall be deemed to be "Proprietary Information."
                                         In particular, Proprietary Information includes, without limitation, any trade secrets,
                                         confidential information, ideas, inventions or research and development information;
                                         matters of a technical nature, including technology; notes, products, know-how, engineering
                                         or other data (including test data and data files); specifications, processes, techniques,
                                         formulae or work-in-process; manufacturing, planning or marketing procedures, clinical
                                         data and regulatory strategies or information; accounting, financial or pricing procedures
                                         or information, budgets or projections, or personnel or salary structure/compensation
                                         information; information regarding suppliers, clients, customers, employees, contractors,
                                         investors or investigators of the Company, information which has been designated in writing
                                         as confidential by the Company; programs, procedures (including operating procedures),
                                         processes, methods, guidelines, policies, proposals or contracts; computer software,
                                         data bases or programming; and any other information which, if divulged to a third party,
                                         could have an adverse impact on the Company, or on any third party to which it owes a
                                         confidentiality obligation. In addition, "Proprietary Information" includes
                                         any of the foregoing relating to the past, present or future operations, organization,
                                         projects, finances, business interests, methodology or affairs of any third party to
                                         which the Company owes a duty of confidentiality including, without limitation, the mere
                                         fact that the Company is or may be working with or for any client.

		(b)	The
                                         obligations of confidentiality shall not apply to any Proprietary Information that was
                                         known by the Candidate at the time of disclosure to it by
                                         such Company, or that is independently developed or discovered
                                         by the Candidate after disclosure by such Company, without the aid, application or use
                                         of any item of such Company's Proprietary Information, as evidenced by written records;
                                         now, or subsequently becomes, through no act or failure to act on the part of the Candidate,
                                         generally known or available; is disclosed to the Candidate by a third party authorized
                                         to disclose it; or is required by law or by court or administrative order to be disclosed;
                                         provided, that the Candidate shall have first given prompt notice to such Company of
                                         such required disclosure.

    	 	2	 

     

    

		(c)	Candidate
                                         shall exercise due care to prevent the unauthorized use or disclosure of the Company's
                                         Proprietary Information, and shall not, without the Company's prior written consent,
                                         disclose or otherwise make available, directly or indirectly, any item of the Company's
                                         Proprietary Information to any person or entity other than those employees, independent
                                         contractors or agents of the Candidate (collectively, "Representatives"), to
                                         the extent such Representatives reasonably need to know the same in order to evaluate
                                         such Proprietary Information, to participate in the business relationship between the
                                         parties, or to make decisions or render advice in connection therewith. Candidate shall
                                         advise its Representatives who have access to the Company's Proprietary Information of
                                         the confidential and proprietary nature thereof, and agrees that such Representatives
                                         shall be bound by terms of confidentiality and restrictions on use with respect thereto
                                         that are at least as restrictive as the terms of this Agreement.

		(d)	Candidate
                                         shall exercise due care to prevent the unauthorized use or disclosure of the Company's
                                         Proprietary Information, and shall not, without the Company's prior written consent,
                                         disclose or otherwise make available, directly or indirectly, any item of the Company's
                                         Proprietary Information to any person or entity other than those employees, independent
                                         contractors or agents of the Candidate (collectively, "Representatives"), to
                                         the extent such Representatives reasonably need to know the same in order to participate
                                         in any business relationship between the parties, or to make decisions or render advice
                                         in connection therewith. Candidate shall advise its Representatives who have access to
                                         the Company's Proprietary Information of the confidential and proprietary nature thereof,
                                         and agrees that such Representatives shall be bound by terms of confidentiality and restrictions
                                         on use with respect thereto that are at least as restrictive as the terms of this Agreement.

		(e)	Candidate
                                         shall use the Company's Proprietary Information solely for the purposes of performing
                                         his duties pursuant to this Agreement and shall not make any other use of the Company's
                                         Proprietary Information without the Company's specific written authorization.

		(f)	All
                                         Proprietary Information of the Company (including all copies thereof) shall be and at
                                         all times remain the property of such Company, and all non-oral Proprietary Information
                                         of the Company which is then in the Candidate's possession or control shall be destroyed
                                         or returned to the Company promptly upon its request at any time, and in any event, no
                                         later than 60 days following any expiration or termination of this Agreement.

		(g)	Nothing
                                         in this Agreement shall be construed, by implication or otherwise, as a grant of any
                                         right or license to trademarks, inventions, copyrights or patents, as a grant of a license
                                         to either Candidate to use any of the Company's Proprietary Information except as expressly
                                         set forth herein.

		(h)	The
                                         provisions of Section 7 of this Agreement shall survive until such time as all Confidential
                                         Information disclosed hereafter becomes publically known and made generally available
                                         through no action or inaction of Candidate.

    	 	3	 

     

    

		8.	Compensation.

		(a)	For
                                         performance of duties pursuant to Section 1 of this Agreement, Candidate will receive,
                                         no later than ten days from the execution of this agreement, 3,000,000 shares of Series
                                         M Preferred of the Company. In addition, on the first, second and third anniversary of
                                         this agreement, the Candidate shall receive an additional 1,000,000 shares of Series
                                         M Preferred stock of the Company (for a total of 6,000,000 shares during the term of
                                         this agreement). The Series M Preferred shares are convertible into common shares of
                                         the Company upon either a) the execution of a licensing agreement for the Company's NR2F6
                                         intellectual property, or, b) the third anniversary of this agreement. Therefore, it
                                         is expressly acknowledged that the Candidate shall be entitled to convert the Series
                                         M Preferred shares upon the completion of a three-year period as the Chairman of the
                                         Business Advisory Board. Lastly, if the Candidate's term is less than three years, the
                                         shares that the Candidate receives on an annual basis will be prorated, and will remain
                                         eligible for conversion into common shares of the Company on the third anniversary of
                                         this agreement.

		(b)	For
                                         performance of duties pursuant to Section 2 of this Agreement, Candidate will receive:

		(i)	In
                                         the event that an Advisory Candidate identified and introduced by the Candidate to the
                                         Company serves as a member of the Business Advisory Board of the Company, you shall receive,
                                         ten business days subsequent to the completion of 12 months service by the Advisory Candidate
                                         as a member of the Business Advisory Board of the Company, a referral fee equal to 5%
                                         (paid to you in Series M Preferred shares of the Company) of the shares of the Series
                                         M Preferred shares of the Company issued to the referred Candidate.

		(ii)	In
                                         the event of a Transaction with one or more Buyers of the Company's securities, such
                                         Buyers not previously known to the Company and identified and introduced by you to the
                                         Company, a referral fee equal to 5% (paid to you in Series M Preferred shares of the
                                         Company) of the shares of common stock of the Company purchased by the Buyer.

		9.	Restricted
                                         Securities Acknowledgement

 

Candidate
acknowledges that any securities issued pursuant to this Agreement that shall not be registered pursuant to the Securities Act
of 1933 shall constitute "restricted securities" as that term is defined in Rule 144 promulgated under the Securities
Act of 1933, and shall contain the following restrictive legend:

 

 

 

"THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR SECURITIES LAWS
OF ANY STATE AND MAY NOT BE OFFERED, SOLD, ASSIGNED, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS OR
PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION UNDER THE ACT OR SUCH LAWS
AND, IF REQUESTED BY THE COMPANY, UPON DELIVERY OF AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT THE
PROPOSED TRANSFER IS EXEMPT FROM THE ACT OR SUCH LAWS."

 

    	 	4	 

     

    

 

		10.	Representations
                                         And Warranties Of Company.

 

a)
Company is a corporation duly organized, validly existing and in good standing under the laws of the state its incorporation and
has the requisite corporate power and authority to enter into and perform its obligations under this Agreement without the consent,
approval or authorization of, or obligation to notify, any person, entity or governmental agency which consent has not been obtained.

 

 (c) The execution, delivery and performance of this Agreement by Company does not and shall not constitute Company's breach of any statute or regulation or ordinance of any governmental authority, and shall not conflict with or result in a breach of or default under any of the terms, conditions, or provisions of any order, writ, injunction, decree, contract, agreement, or instrument to which the Company is a party, or by which Company is or may be bound.

		11.	Representation
                                         and Warranties of the Candidate.

 

 (a) Candidate has the requisite power and authority to enter into and perform his obligations under this Agreement without the consent, approval or authorization of, or obligation to notify, any person, entity or governmental agency which consent has not been obtained.

 

(b) 
The execution, delivery and performance of this
Agreement by Candidate does not and shall not constitute Candidate's breach of any statute or regulation or ordinance of any governmental
authority, and shall not conflict with or result in a breach of or default under any of the terms, conditions, or provisions of
any order, writ, injunction, decree, contract, agreement, or instrument to which the Candidate is a party, or by which Candidate
is or may be bound.

 

		12.	Execution

 

This
Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same
Agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it
being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by
facsimile transmission, such signature shall create a valid and binding obligation of the party executing (or on whose behalf
such signature is executed) with the same force and effect as if such facsimile signature page were an original
thereof.

 

    	 	5	 

     

    

 

		13.	Entire
                                         Agreement

 

This
Agreement constitutes a final written expression of all the terms of the Agreement between the parties regarding the subject matter
hereof, are a complete and exclusive statement of those terms, and supersedes all prior and contemporaneous Agreements, understandings,
and representations between the parties.

 

 

		14.	Severability

 

If
any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and enforceability of the
remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt
to agree upon a valid and enforceable provision that is a reasonable substitute therefore, and upon so agreeing, shall incorporate
such substitute provision in this Agreement

 

 

		15.	Governing
                                         Law, Venue, Waiver Of Jury Trial

 

All
questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed
and enforced in accordance with the internal laws of the State of California, without regard to the principles of conflicts of
law thereof. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in California
for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or inconvenient venue for such
proceeding. If either party shall commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing
party in such action or proceeding shall be reimbursed by the other party for its attorneys' fees and other costs and expenses
incurred with the investigation, preparation and prosecution of such action or proceeding.

 

    	 	6	 

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

	Company	Candidate
	By:/s/Todd
    Caven	By:
    JP Millon
	Its:
    CFO	 

 

    	 	7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}]]